You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Type 2 Inflammation

Barrier Disruption in Atopic Dermatitis and Food Allergy

Watch this brief video, as Dr. Peter Lio outlines the impact of barrier disruption in AD on the development of food allergy.

Peter Lio
MD
Peter Lio

Learning objectives

  • Learn about the implications of a compromised skin barrier in managing and preventing food allergies in individuals with atopic dermatitis

Description

In this short clip, Dr. Peter Lio describes how barrier disruption in atopic dermatitis can increase the risk of food allergies, as a compromised skin barrier may allow allergens to penetrate more easily, triggering immune responses and potentially leading to the development of food allergen sensitization.

Tags
symptomspediatricexpert insightsmechanism of disease
MAT-US-2306092 V2 P Exp Date: 07/28/2025

About this expert

Dermatology

Peter Lio

MD

Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai, NY; Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine, Chicago, Illinois, US

See author’s profile
Peter Lio

Related resources

Learn more about how dysregulated type 2 inflammation contributes to polymorphous lesions and dermal epidermal splitting in bullous pemphigoid
Dermatology
Infographic

Bullous Pemphigoid (BP) Pathophysiology Infographic

Barrier Disruption in Atopic Dermatitis and Food Allergy
Type 2 Inflammation
expert video

Barrier Disruption in Atopic Dermatitis and Food Allergy

Type 2 Inflammation in Atopic Dermatitis and Food Allergy
Type 2 Inflammation
expert video

Type 2 Inflammation in Atopic Dermatitis and Food Allergy

Assessment of Atopic Dermatitis Burden in Children and Adolescents
Dermatology
expert video

Assessment of Atopic Dermatitis Burden in Children and Adolescents

Clinical Assessment of Prurigo Nodularis
Dermatology
expert video

Clinical Assessment of Prurigo Nodularis

Comorbidities in Children and Adolescents with Atopic Dermatitis
Dermatology
expert video

Comorbidities in Children and Adolescents with Atopic Dermatitis

A Common Link: The Role of Type 2 Inflammation in the Clinical Presentation of AD, PN, and CSU
Dermatology
expert video

A Common Link: The Role of Type 2 Inflammation in the Clinical Presentation of AD, PN, and CSU

An Overview of Prurigo Nodularis
Dermatology
expert video

An Overview of Prurigo Nodularis

Atopic Dermatitis as a Risk Factor for Food Allergy
Type 2 Inflammation
expert video

Atopic Dermatitis as a Risk Factor for Food Allergy

EAACI 2022 | Unmet Needs in the Diagnosis and Management of Chronic Urticaria
Dermatology
expert video

EAACI 2022 | Unmet Needs in the Diagnosis and Management of Chronic Urticaria

Itch in AD, PN, and CSU: Contributions of Type 2 Inflammation
Dermatology
expert video

Itch in AD, PN, and CSU: Contributions of Type 2 Inflammation

The Journey to Diagnosis: Considerations For AD, PN, and CSU
Dermatology
expert video

The Journey to Diagnosis: Considerations For AD, PN, and CSU

Pathophysiology of Prurigo Nodularis
Dermatology
expert video

Pathophysiology of Prurigo Nodularis

What is the disease burden of atopic dermatitis on children and their families
Dermatology
expert video

What is the disease burden of atopic dermatitis on children and their families

The Burden of Disease in Atopic Dermatitis
Dermatology
expert video

The Burden of Disease in Atopic Dermatitis

Type 2 Inflammation and Its Role in Associated Dermatologic Diseases: A Two-Part Series
Type 2 Inflammation
expert video

Type 2 Inflammation and Its Role in Associated Dermatologic Diseases: A Two-Part Series

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice
Dermatology
expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

The Journey of Diagnosis: Disease Burden and Diagnostic Considerations for Atopic Dermatitis and Prurigo Nodularis
Dermatology
expert video

The Journey of Diagnosis: Disease Burden and Diagnostic Considerations for Atopic Dermatitis and Prurigo Nodularis

Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis
Dermatology
expert video

Type 2 Inflammation: A Common Link Between Atopic Dermatitis and Prurigo Nodularis

The Burden of Chronic Spontaneous Urticaria: One Patient’s Journey to Diagnosis
Dermatology
videoanimation

The Burden of Chronic Spontaneous Urticaria: One Patient’s Journey to Diagnosis

Explore the clinical presentations of bullous pemphigoid (BP), the steps for diagnosis, and the burden of disease.
Dermatology
Infographic

Bullous Pemphigoid (BP): Don't Miss the Diagnosis

The Role of Mast Cells, Basophils, and Type 2 Cells and Cytokines in CSU
Dermatology
Infographic

The Role of Mast Cells, Basophils, and Type 2 Cells and Cytokines in CSU

Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
Dermatology
expert video

Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology

Disease Modification Concepts in AD
Dermatology
expert video

Disease Modification Concepts in AD

Barrier disruption in AD and the development of environmental and food allergies
Dermatology
expert video

Barrier disruption in AD and the development of environmental and food allergies

Skin Barrier Dysfunction and Type 2 Inflammation in Atopic Dermatitis
Dermatology
videoanimation

Skin Barrier Dysfunction and Type 2 Inflammation in Atopic Dermatitis

CSU is Associated With a High Burden and Impact on Quality of Life
Dermatology
expert video

CSU is Associated With a High Burden and Impact on Quality of Life

How type 2 cytokines can amplify inflammatory response in CSU
Dermatology
expert video

How type 2 cytokines can amplify inflammatory response in CSU

AD and PN: Diagnosis and Impact on Quality of Life
Dermatology
expert video

AD and PN: Diagnosis and Impact on Quality of Life

AD, PN, and CSU: Distinct, Pruritic Diseases
Dermatology
expert video

AD, PN, and CSU: Distinct, Pruritic Diseases

Atopic Dermatitis (AD) and Prurigo Nodularis (PN): Distinct Diseases with Shared Characteristics
Dermatology
interactivity

Atopic Dermatitis (AD) and Prurigo Nodularis (PN): Distinct Diseases with Shared Characteristics

Chronic Spontaneous Urticaria (CSU) Interactive Patient Case
Dermatology
interactivity

Chronic Spontaneous Urticaria (CSU) Interactive Patient Case

Chronic Spontaneous Urticaria: Disease Overview
Dermatology
interactivity

Chronic Spontaneous Urticaria: Disease Overview

Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU
Dermatology
expert video

Contributions of Type 2 Cytokines to Chronic Pruritus in AD, PN, and CSU

Cutaneous Manifestations in AD & PN: Role of Type 2 Inflammation
Dermatology
expert video

Cutaneous Manifestations in AD & PN: Role of Type 2 Inflammation

Disease-Specific Aspects of Itch in AD, PN, and CSU
Dermatology
expert video

Disease-Specific Aspects of Itch in AD, PN, and CSU

Effect of Type 2 Inflammation on Skin Barrier Function in AD​
Dermatology
interactivity

Effect of Type 2 Inflammation on Skin Barrier Function in AD​

Fibrosis and Type 2 Inflammation in PN
Dermatology
expert video

Fibrosis and Type 2 Inflammation in PN

Mechanisms of Pruritus in AD & PN: Role of Type 2 Inflammation
Dermatology
expert video

Mechanisms of Pruritus in AD & PN: Role of Type 2 Inflammation

Prurigo Nodularis (PN) Case Studies
Dermatology
interactivity

Prurigo Nodularis (PN) Case Studies

Type 2 Inflammation and Neuronal Sensitization in AD and PN
Dermatology
interactivity

Type 2 Inflammation and Neuronal Sensitization in AD and PN

Neuroimmune Axis and Pruritus in PN
Dermatology
expert video

Neuroimmune Axis and Pruritus in PN

ADVENT On Air - Dermatology
Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

ADVENT On Air | Common Drivers of Type 2 Inflammatory Diseases
Type 2 Inflammation
Podcast

ADVENT On Air | Common Drivers of Type 2 Inflammatory Diseases

Neuroimmune Axis Dysregulation and Type 2 Inflammation: Shared Roles in AD, PN, and CSU
Dermatology
expert video

Neuroimmune Axis Dysregulation and Type 2 Inflammation: Shared Roles in AD, PN, and CSU

PN and AD: Distinct Diseases with Underlying Type 2 Inflammation
Dermatology
expert video

PN and AD: Distinct Diseases with Underlying Type 2 Inflammation

Presentation and Diagnosis of AD and PN
Dermatology
expert video

Presentation and Diagnosis of AD and PN

Type 2 Inflammation and Chronic Pruritus in AD and PN
Dermatology
expert video

Type 2 Inflammation and Chronic Pruritus in AD and PN

Type 2 Inflammation and Cutaneous Manifestation in AD and PN
Dermatology
expert video

Type 2 Inflammation and Cutaneous Manifestation in AD and PN

Type 2 Inflammation and Neuroimmune Axis Dysregulation in AD, PN, and CSU
Dermatology
expert video

Type 2 Inflammation and Neuroimmune Axis Dysregulation in AD, PN, and CSU

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region